跳轉至內容
Merck
全部照片(1)

文件

319M-1

Sigma-Aldrich

Cytokeratin 19 (A53-B/A2.26) Mouse Monoclonal Antibody

登入查看組織和合約定價
全部照片(1)

About This Item

分類程式碼代碼:
12352203
NACRES:
NA.41

生物源

mouse

品質等級

100
500

共軛

unconjugated

抗體表格

diluted ascites fluid

抗體產品種類

primary antibodies

無性繁殖

A53-B/A2.26, monoclonal

描述

For In Vitro Diagnostic Use in Select Regions (See Chart)

形狀

buffered aqueous solution

物種活性

human

包裝

vial of 0.1 mL concentrate (319M-14)
vial of 0.5 mL concentrate (319M-15)
bottle of 1.0 mL predilute (319M-17)
vial of 1.0 mL concentrate (319M-16)
bottle of 7.0 mL predilute (319M-18)

製造商／商標名

Cell Marque™

技術

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:500

同型

IgG2aλ

控制

colon

運輸包裝

wet ice

儲存溫度

2-8°C

視覺化

cytoplasmic

基因資訊

human ... KRT19(3880)

相關類別

一般說明

Anti-cytokeratin 19 reacts with simple and complex epithelia, including the glandular andductal epithelium of organs such as the gastrointestinal tract and breast and squamousepithelium. CK19 expression is seen in many carcinomas, including carcinomas of the colon,stomach, pancreas, biliary tract, liver, and breast. Anti-cytokeratin 19 has been used tohelp identify neoplasms in the liver and as an aid in the identification of thyroid papillarycarcinoma.

品質


IVD
IVD
IVD
RUO

聯結

Cytokeratin 19 Positive Control Slides , Product No. 319S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

外觀

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

準備報告

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

其他說明

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

法律資訊

Cell Marque is a trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our 產品選擇工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類（WGK）

WGK 2

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

K Y Lam et al.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 27(7), 631-635 (2001-10-24)
The aim of this study was to establish the cytokeratin expression profile of different types of thyroid carcinoma. The expression of cytokeratins (CKs) 1, 4, 6, 7, 10/13, 18, 19 and 20 in 153 thyroid carcinomas were examined by immunohistochemistry.
Z W Baloch et al.
Human pathology, 30(10), 1166-1171 (1999-10-26)
The follicular variant of papillary carcinoma (FVPTC) is characterized by follicular growth pattern and tumor cells with appropriate nuclear features of papillary carcinoma. However, occasionally these lesions may show focal or multifocal instead of diffuse distribution of nuclear features of
Vaneet Kaur et al.
Journal of oral and maxillofacial pathology : JOMFP, 22(1), 112-115 (2018-05-08)
We report a rare and unusual case of a Peripheral Ameloblastic Fibro-Dentinoma (PAFD) occurring in a 3 year old Indian boy. The boy presented to the hospital complaining of swelling in anterior maxillary region with a history of trauma. Periapical
M F Beesley et al.
Histopathology, 41(3), 236-243 (2002-09-05)
The immunohistochemical expression of cytokeratin 19 (CK 19) and galectin-3 was evaluated in 69 thyroid lesions to assess their potential as markers in the diagnosis and classification of thyroid malignancy. The following were studied: 26 cases of papillary carcinoma, 12
S M Nasser et al.
Cancer, 90(5), 307-311 (2000-10-20)
Papillary thyroid carcinoma is the most common malignant neoplasm of the thyroid gland, and fine-needle aspiration biopsy (FNAB) often is the initial diagnostic method used in its detection. Prior studies have shown that immunohistochemical staining for various cytokeratins in general
查看所有相關論文

文章

Immunohistochemistry Applications in Gastrointestinal Cancer

Colorectal cancer is the third most common cancer in both men and women. An estimated 136,000 cases of colorectal cancer are expected to occur in 2016.

免疫組織化學在胃腸道癌症中的應用

結腸直腸癌是男性和女性的第三大常見癌症。預計 2016 年會有 136,000 例結腸直腸癌病例。

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務